• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

RealTalk MS

  • Home
  • Past Episodes
  • Videos
  • About RealTalk MS
  • Press Kit
  • Contact Us

Past Podcast Episodes

Episode 450: Exercise is Medicine for People with MS with Dr. Robert Motl


An exercise program can be hard to start and even more difficult to stick with. But the evidence-based benefits speak for themselves. For people living with MS, it can mean improving quality of life without having to rely on a pill, injection, or infusion. And exercise is 100% affordable!

Dr. Rob Motl

Dr. Robert Motl, the Director of the Exercise Neuroscience Research Laboratory at the College of Applied Health Sciences at the University of Illinois Chicago, joins me to discuss how exercise can improve MS-related brain fog, reduce fatigue, and perhaps even support myelin repair.

We'll also share the results of a study that shows having mononucleosis is a significant risk factor for developing MS.

And we'll tell you about a powerful imaging agent that can identify which immune cells are causing the inflammatory activity that drives MS, determine disease severity, and track the immune system's response to disease-modifying therapy. It's a potential game-changer in MS care.

We have a lot to talk about! Are you ready for RealTalk MS??!


This Week: Evidence-based benefits of exercise for people living with MS  :22

Study results show that having mono increases the chance that someone will develop MS  1:28

Researchers have created an imaging agent with the potential to be a game-changer in diagnosing and treating MS  4:29

Dr. Robert Motl explains how and why exercise can be medicine for people with MS  10:04

Share this episode  31:50

Next week  32:10


SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/450

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!


LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com

STUDY: Risk of Multiple Sclerosis Among Persons with Epstein-Barr Virus-Positive Mononucleosis
https://www.neurology.org/doi/10.1212/WN9.0000000000000082

STUDY: A Radiolabeled Dendrimer Non-Invasively Identifies and Tracks Innate Immune Cell Activation in a Mouse Model of Experimental Autoimmune Encephalomyelitis
https://www.nature.com/articles/s41467-025-67907-x

AbleNOW
https://ablenow.com

JOIN: The RealTalk MS Facebook Group
https://facebook.com/groups/realtalkms

REVIEW: Give RealTalk MS a rating and review
http://www.realtalkms.com/review


Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 450
Guest: Dr. Robert Motl

Privacy Policy

 

Filed Under: Uncategorized

Episode 449: Putting People Affected by MS at the Center of MS Research with Sara Loud, Stephanie Buxhoeveden, and Hollie Schmidt


When you join the iConquer MS community, you're no longer just a patient; you become a research partner. Not just a data point in someone's study. You become the person to suggest the study, to help define the study, and to participate in sharing the outcome of the study.

I Conquer MS

In this week's episode, I talk with the iConquer MS leadership team about what it means to be part of this people-powered research revolution and how iConquer MS keeps people affected by MS at the center of MS research.

The National Institutes of Health has just published a Strategic Plan for Disability Health Research. We're sharing all the details.

And a research team analyzed data from 20 global studies to determine whether anti-CD20 disease-modifying therapies (Ocrevus, Kesimpta, Briumvi) were cost-effective. We're sharing their somewhat surprising results.

And a research team analyzed data from 20 global studies to determine whether anti-CD20 disease-modifying therapies (Ocrevus, Kesimpta, Briumvi) were cost-effective. We're sharing their somewhat surprising results.

We have a lot to talk about! Are you ready for RealTalk MS??!


This Week: We're talking about people-powered MS research  :22

The NIH has published a Strategic Plan for Disability Health Research  1:15

Researchers determine whether anti-CD20 disease-modifying therapies (Ocrevus, Kesimpta, Briumvi) are cost-effective  6:05

Sara Loud, Stephanie Buxhoeveden, and Hollie Schmidt discuss what it means to put people affected by MS at the center of MS research  12:41

Share this episode  36:26

Next week  36:45


SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/449

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!


LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes at www.RealTalkMS.com

iConquer MS
https://iconquerms.org

National Institutes of Health Strategic Plan for Disability Health Research
https://dpcpsi.nih.gov/disabilityhealthresearch

STUDY: Economic Value of Anti-CD20 Therapies in Multiple Sclerosis: A Systematic Review of Cost-Effectiveness Studies
https://journals.sagepub.com/doi/10.1177/17562864261426816

AbleNOW
https://ablenow.com

JOIN: The RealTalk MS Facebook Group
https://facebook.com/groups/realtalkms

REVIEW: Give RealTalk MS a rating and review
http://www.realtalkms.com/review


Follow RealTalk MS on X, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 449
Guests: Sara Loud, Stephanie Buxoeveden, and Hollie Schmidt

Privacy Policy

Filed Under: Uncategorized

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Interim pages omitted …
  • Page 255
  • Go to Next Page »

Primary Sidebar

ARE YOU ON OUR MAILING LIST?

Sign up to receive email updates from RealTalk MS. You’ll get a personal advance heads-up about every upcoming podcast episode.

And P.S. — We promise to keep your private information private! We won’t sell it, trade it, or share it.

Connect With Us

  • Email
  • Facebook
  • Instagram
  • LinkedIn
  • RSS
  • Twitter
  • YouTube

Copyright © 2026 RealTalk MS